Evidence map›Paper›PMID 32165539›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

DNA origami protection and molecular interfacing through engineered sequence-defined peptoids.

Shih-Ting Wang, Melissa A Gray, Sunting Xuan, Yiyang Lin, James Byrnes, Andy I Nguyen, Nevena Todorova, Molly M Stevens, Carolyn R Bertozzi, Ronald N Zuckermann and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
8.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 130 citations in OpenAlex.

  1. The Ion Permeability of DNA Nanotube Channels.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Sequence-defined peptoidsChemical science · 2025
    Article
  9. Review
  10. Article
  11. Gel-Based Analysis of DNA Nanostructure Biostability.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  12. Raman Imaging of Targeted Drug Delivery with DNA-Based Nano-Optical Devices.Small (Weinheim an der Bergstrasse, Germany) · 2024
    Article
  13. Article
  14. Studying Biomolecular Protein Complexes via Origami and 3D-Printed Models.International journal of molecular sciences · 2024
    Article
  15. Advancements in Aptamer-Driven DNA Nanostructures for Precision Drug Delivery.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Shih-Ting WangCenter for Functional Nanomaterials, Brookhaven National Laboratory, Upton, NY 11973.
Melissa A GrayDepartment of Chemistry, Stanford University, Stanford, CA 94305.
Sunting XuanThe Molecular Foundry, Lawrence Berkeley National Laboratory, Berkeley, CA 94720.ORCID 0000-0001-6499-9122
Yiyang LinDepartment of Materials, Imperial College London, SW7 2AZ, London, UK.
James ByrnesPhoton Science Division, National Synchrotron Light Source II, Brookhaven National Laboratory, Upton, NY 11973.
Andy I NguyenThe Molecular Foundry, Lawrence Berkeley National Laboratory, Berkeley, CA 94720.
Nevena TodorovaSchool of Engineering, Royal Melbourne Institute of Technology, Melbourne, VIC 3001, Australia.ORCID 0000-0001-6358-2974
Molly M StevensDepartment of Materials, Imperial College London, SW7 2AZ, London, UK.
Carolyn R BertozziDepartment of Chemistry, Stanford University, Stanford, CA 94305.ORCID 0000-0003-4482-2754
Ronald N ZuckermannThe Molecular Foundry, Lawrence Berkeley National Laboratory, Berkeley, CA 94720.ORCID 0000-0002-3055-8860
Oleg GangCenter for Functional Nanomaterials, Brookhaven National Laboratory, Upton, NY 11973; og2226@columbia.edu.
Brookhaven National Laboratory · USLawrence Berkeley National Laboratory · USNIHR Imperial Biomedical Research Centre · GBHoward Hughes Medical Institute · USStanford University · US

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Vittorio Sebastiano · 2007 to 2026
$71.4M
Life Science and Biomedical technology Research center at NSLS-II LSBRP41GM111244 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI MCSWEENEY, SEAN · 2014 to 2018
$16.4M
Metabolic Engineering with Bioorthogonal Chemical ReportersR37GM058867 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI BERTOZZI, CAROLYN · 2009 to 2018
$4.7M
A Simultaneous SAXS/WAXS Detector System for Solving Biological StructuresS10OD012331 · OD · STATE UNIVERSITY NEW YORK STONY BROOK · PI ALLAIRE, MARC · 2012 to 2012
$1.1M
NIGMS NIH HHS P41 GM111244NIH HHS S10 OD012331
6 · The paper itself

Abstract

DNA nanotechnology has established approaches for designing programmable and precisely controlled nanoscale architectures through specific Watson-Crick base-pairing, molecular plasticity, and intermolecular connectivity. In particular, superior control over DNA origami structures could be beneficial for biomedical applications, including biosensing, in vivo imaging, and drug and gene delivery. However, protecting DNA origami structures in complex biological fluids while preserving their structural characteristics remains a major challenge for enabling these applications. Here, we developed a class of structurally well-defined peptoids to protect DNA origamis in ionic and bioactive conditions and systematically explored the effects of peptoid architecture and sequence dependency on DNA origami stability. The applicability of this approach for drug delivery, bioimaging, and cell targeting was also demonstrated. A series of peptoids (PE1-9) with two types of architectures, termed as "brush" and "block," were built from positively charged monomers and neutral oligo-ethyleneoxy monomers, where certain designs were found to greatly enhance the stability of DNA origami. Through experimental and molecular dynamics studies, we demonstrated the role of sequence-dependent electrostatic interactions of peptoids with the DNA backbone. We showed that octahedral DNA origamis coated with peptoid (PE2) can be used as carriers for anticancer drug and protein, where the peptoid modulated the rate of drug release and prolonged protein stability against proteolytic hydrolysis. Finally, we synthesized two alkyne-modified peptoids (PE8 and PE9), conjugated with fluorophore and antibody, to make stable DNA origamis with imaging and cell-targeting capabilities. Our results demonstrate an approach toward functional and physiologically stable DNA origami for biomedical applications.

Indexed as

DNADrug Delivery SystemsMolecular Dynamics SimulationMolecular StructureNanostructuresNanotechnologyPeptoidsStatic ElectricityDNAPeptoidsDNA nanotechnologymolecular coatingpeptoid

Identifiers

PMID32165539
PMCPMC7104344
OpenAlexW3011195687

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.